Establishing risk of human experimentation with drugs: lessons from TGN1412

被引：103
作者：
Kenter, M. J. H.
Cohen, A. F.
机构：
[1] CHDR, NL-2333 CL Leiden, Netherlands
[2] Cent Comm Res Invilving Human Subjects, The Hague, Netherlands
来源：
LANCET | 2006年 / 368卷 / 9544期
关键词：
D O I：
10.1016/S0140-6736(06)69562-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1387 / 1391
页数：5
相关论文
共 30 条
[21]   Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma [J].
Phan, GQ ;
Yang, JC ;
Sherry, RM ;
Hwu, P ;
Topalian, SL ;
Schwartzentruber, DJ ;
Restifo, NP ;
Haworth, LR ;
Seipp, CA ;
Freezer, LJ ;
Morton, KE ;
Mavroukakis, SA ;
Duray, PH ;
Steinberg, SM ;
Allison, JP ;
Davis, TA ;
Rosenberg, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8372-8377
[22]   TGN1412 -: a regulator's perspective [J].
Schneider, CK ;
Kalinke, U ;
Löwer, J .
NATURE BIOTECHNOLOGY, 2006, 24 (05) :493-496
[23]   T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs [J].
Smith, JA ;
Bluestone, JA .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (05) :648-654
[24]   Protecting research subjects - The crisis at Johns Hopkins. [J].
Steinbrook, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :716-720
[25]  
*TEGENERO AG, 2005, TEG IMM INV BROCH TG
[26]   CD28 signaling in neutrophil induces T-cell chemotactic factor(s) modulating T-cell response [J].
Venuprasad, K ;
Chattopadhyay, S ;
Saha, B .
HUMAN IMMUNOLOGY, 2003, 64 (01) :38-43
[27]  
Venuprasad K, 2001, EUR J IMMUNOL, V31, P1536, DOI 10.1002/1521-4141(200105)31:5<1536::AID-IMMU1536>3.0.CO
[28]  
2-8
[29]   London's disastrous drug trial has serious side effects for research [J].
Wadman, M .
NATURE, 2006, 440 (7083) :388-389
[30]  
ZARAFONETIS CJD, 1978, CLIN PHARMACOL THER, V24, P127
123